Independent Advisor Alliance Senseonics Holdings, Inc. Transaction History

Independent Advisor Alliance

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.68 - $1.25 $17,860 - $32,832	-26,266 Reduced 68.61%	12,019 $8,000
Q4 2022 Feb 13, 2023	BUY	$0.96 - $1.34 $144 - $201	150 Added 0.39%	38,285 $39,000
Q3 2022 Nov 04, 2022	BUY	$1.02 - $2.23 $26,137 - $57,143	25,625 Added 204.84%	38,135 $50,000
Q2 2022 Aug 04, 2022	SELL	$0.94 - $1.94 $3,634 - $7,501	-3,867 Reduced 23.61%	12,510 $13,000
Q3 2021 Nov 01, 2021	BUY	$2.77 - $4.05 $69 - $101	25 Added 0.15%	16,377 $56,000
Q2 2021 Aug 12, 2021	SELL	$1.71 - $4.14 $1,624 - $3,932	-950 Reduced 5.49%	16,352 $63,000
Q1 2021 May 14, 2021	BUY	$0.85 - $5.27 $2,739 - $16,985	3,223 Added 22.89%	17,302 $46,000
Q4 2020 Feb 11, 2021	BUY	$0.36 - $0.95 $5,068 - $13,375	14,079 New	14,079 $12,000

138

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $396M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

Stay updated on Independent Advisor Alliance with notifications on news.